Sensimed (Switzerland), a commercial-stage medical device company focused on glaucoma-monitoring, closed a $22M Series C financing. Participants include Wellington Partners, Agate Medical Investments, Vinci Capital/Renaissance PME, Sandoz Family Foundation and ELM Development.
Collective IP | The World’s Largest Technology Transfer Office Marketplace
Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets
Receive Collective IP Account Access HERE